Management of Recurrent Asthma Symptoms After Initial Treatment

Clinical Assessment

The American College of Allergy, Asthma, and Immunology recommends assessing key severity indicators, including ability to complete sentences in one breath, peak expiratory flow (PEF), oxygen saturation, respiratory rate, and heart rate, to determine the need for hospitalization 1, 2
Inability to complete sentences in one breath indicates need for hospitalization, as recommended by the American Thoracic Society 1, 2
PEF values <50% predicted warrant hospitalization, according to the American College of Chest Physicians 1, 2
Oxygen saturation <92% on room air requires admission, as stated by the American Academy of Allergy, Asthma, and Immunology 2
Respiratory rate >25 breaths/min suggests severe exacerbation, as indicated by the American Thoracic Society 1
Heart rate >110 bpm indicates severity, according to the American College of Cardiology 1

The American Academy of Allergy, Asthma, and Immunology recommends administering high-dose albuterol via nebulizer (5 mg) or MDI with spacer (4-12 puffs) every 20-30 minutes for three doses initially, with a strength of evidence rated as high 3
Adding ipratropium bromide 0.5 mg via nebulizer or 8 puffs via MDI to each albuterol treatment reduces hospitalization rates, particularly in patients with severe airflow obstruction, as recommended by the American College of Chest Physicians 3, 2
The American Thoracic Society suggests reinitiating oral prednisone 30-60 mg daily (or 0.6 mg/kg body weight) for 1-3 weeks, with a strength of evidence rated as moderate 1, 4
Corticosteroids take 6-12 hours to manifest anti-inflammatory effects, so early administration is critical, as stated by the American Academy of Allergy, Asthma, and Immunology 4

The American College of Allergy, Asthma, and Immunology recommends reassessing patients after 15-30 minutes of initial treatment to determine the need for hospitalization, with a strength of evidence rated as high 4
If improved, continue outpatient management with prednisone 30-60 mg daily for 1-3 weeks, albuterol nebulizer or inhaler every 4 hours as needed, and continue or increase inhaled corticosteroid dose, as recommended by the American Thoracic Society 1, 4
Provide peak flow meter and written asthma action plan, as suggested by the American Academy of Allergy, Asthma, and Immunology 2
Schedule primary care follow-up within 1 week and respiratory specialist within 4 weeks, as recommended by the American College of Chest Physicians 4, 2

The American Academy of Allergy, Asthma, and Immunology recommends not using antibiotics unless there is clear evidence of bacterial infection, with a strength of evidence rated as high 1
Do not use sedatives, as they are contraindicated in asthma exacerbations and can worsen respiratory depression, as stated by the American Thoracic Society 1
Do not discharge without ensuring adequate steroid duration, as the 5-6 day Medrol dose pack is often insufficient, and this patient's relapse demonstrates the need for longer courses (1-3 weeks), as recommended by the American College of Allergy, Asthma, and Immunology 1, 4